Pharmacokinetic studies of 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186) - Protein binding and distribution to red blood cell

Japanese Pharmacology and Therapeutics

Volumn 25, Issue SUPPL. 7, 1997, Pages 252-253

  Yamamoto, Minako ^a   Takamatsu, Yasuo ^a  

^a MITSUBISHI CHEMICAL CORPORATION   (Japan)

Author keywords

Albumin; MCI 186; Protein binding; Red blood cell; Serum

Indexed keywords

ALBUMIN; CARBON 14; CHARCOAL; NORPHENAZONE; ORGANIC SOLVENT; PLASMA PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOG; DRUG DISTRIBUTION; DRUG PROTEIN BINDING; DRUG STABILITY; EQUILIBRIUM DIALYSIS; ERYTHROCYTE; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; NORMAL HUMAN; RAT; SPECIES DIFFERENCE;

EID: 0031447050     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Kontos HA : Oxygen radicals in cerebral vascular injury. Circ Res 57: 508-516, 1985
2. Halliwell B : Reactive oxygen species and the central nervous system. J Neurochem 59: 1609-1623, 1992
3. Watanabe T et al : Preventive effect of MCI-186 on 15-HPETE induced vascular endothelial cell injury in vitro. Prostaglandins Leukotrienes Essent Fatty Acids 33: 81-87, 1988
4. Watanabe T et al : Protective effects of MCI-186 on cerebral ischemia ; Possible involvement of free radical scavenging and antioxidant actions. J Pharmacol Exp Ther 268: 1597-1604, 1994
5. Abe K et al : Strong attenuation of ischemic and postischemic brain edema in rats by a novel free radical scavenger. Stroke 19: 480-485, 1988
6. Nakagomi T et al : Effect of a new free radical scavenger, MCI-186, on experimental cerebral vasospasm. Sano K et al ed, Cerebral Vasospasm. p141-142, University of Tokyo Press, 1990
7. 3-Methyl-1-phenyl-2-pyrazolin-5-one (MCI-186) 451-462, 1996
8. Sogami M, Foster JF : Isomerization reactions of charcoal-defatted bovine plasma albumin ; The N-F transition and acid expansion. Biochemistry 7: 2172-2182, 1968
9. Pohl LR, Branchflower RV : Covalent binding of electrophilic metabolites to macromolecules. Methods Enzymol 77: 43-50, 1981
10. Steck TL, Kant JA : Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. Methods Enzymol 31: 172-180, 1974
11. Lowry OH et al : Protein measurement with the folin phenol reagent. J Biol Chem 193: 265-275, 1951
12. Borga O et al : Plasma protein binding of basic drugs. Clin Pharmacol Ther 22: 539-544, 1977
13. 3-methyl-1-phenyl-2-pyrazolin-5-one(MCI-186) 11 (5): 463-480, 1996
14. 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186) 11(5): 499-504, 1996
15. Mizuma T et al : Sulphate conjugation enhances reversible binding of drug to human serum albumin. J Pharm Pharmacol 43: 446-448, 1991
16. Shimamura H et al : Identification of tissues responsible for the conjugative metabolism of liquiritigenin in rats ; An analysis based on metabolite kinetics. Biol Pharm Bull 16: 899-907, 1993
17. 3-methyl-1-phenyl-2-pyrazolin-5-one (MCI-186) 11(5): 481-491, 1996